Literature DB >> 16487048

The role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease.

Judith A Potashkin1, Gloria E Meredith.   

Abstract

There are few examples for which the genetic basis for neurodegenerative disease has been identified. For the majority of these disorders, the key to their understanding lies in knowledge of the molecular changes that contribute to altered gene expression and the translational modification of the protein products. Environmental factors play a role in the development and chronicity of neurodegenerative disorders. Environmental stimuli such as hypoxia, toxins, or heavy metals, increase production of reactive oxygen species and lower energy reserves. Chronic exposure to oxidative radicals can adversely affect gene expression and proteolysis. This review summarizes what is currently known about some of the changes in gene expression and protein metabolism that occur after oxidative stress which contribute to neurodegeneration, and reveals areas where more research is clearly needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487048     DOI: 10.1089/ars.2006.8.144

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  24 in total

1.  Natural toxins implicated in the development of Parkinson's disease.

Authors:  Mohamed Salama; Oscar Arias-Carrión
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Gold ions bio-released from metallic gold particles reduce inflammation and apoptosis and increase the regenerative responses in focal brain injury.

Authors:  Agnete Larsen; Kristian Kolind; Dan Sonne Pedersen; Peter Doering; Mie Ostergaard Pedersen; Gorm Danscher; Milena Penkowa; Meredin Stoltenberg
Journal:  Histochem Cell Biol       Date:  2008-06-10       Impact factor: 4.304

3.  Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis.

Authors:  Arzu Toruk Aksar; Nursen Yuksel; Mustafa Gok; Mustafa Cekmen; Yusuf Caglar
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

Review 4.  Oxidative stress in MeHg-induced neurotoxicity.

Authors:  Marcelo Farina; Michael Aschner; João B T Rocha
Journal:  Toxicol Appl Pharmacol       Date:  2011-05-09       Impact factor: 4.219

Review 5.  Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2006-09-07       Impact factor: 21.198

Review 6.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.

Authors:  Michael Maes; Raz Yirmyia; Jens Noraberg; Stefan Brene; Joe Hibbeln; Giulia Perini; Marta Kubera; Petr Bob; Bernard Lerer; Mario Maj
Journal:  Metab Brain Dis       Date:  2008-12-16       Impact factor: 3.584

Review 7.  Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.

Authors:  J L Cadet; I N Krasnova
Journal:  Neurotox Res       Date:  2007-10       Impact factor: 3.911

Review 8.  Molecular bases of methamphetamine-induced neurodegeneration.

Authors:  Jean Lud Cadet; Irina N Krasnova
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

9.  delta-Opioid receptor activation attenuates oxidative injury in the ischemic rat brain.

Authors:  Yilin Yang; Xiwei Xia; Yi Zhang; Qiang Wang; Lu Li; Guanghua Luo; Ying Xia
Journal:  BMC Biol       Date:  2009-08-26       Impact factor: 7.431

10.  The Balance between Life and Death of Cells: Roles of Metallothioneins.

Authors:  Allan Evald Nielsen; Adam Bohr; Milena Penkowa
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.